Results with Lifescozul

Natalia Ferreyra - Breast Cancer- Resultados con LifEscozul™ Breast Cancer

Introduction to the case

Breast cancer is the most common cancer among women and is the second leading cause of death from cancer.

There are two concepts that will make a difference as to the severity of the cancer, these are: In situ and Invasive. In the first case, it refers to the fact that the cancer developed in one place and did not affect other organs, and in the second case, the disease spread to other places.

The risk of breast cancer increases with age, and most cases are diagnosed after the age of 50.

Natalia's case stands out because in August 2017, when she was only 38 years old, she was diagnosed with Invasive Breast Cancer and metastasis to the liver. The disease was very advanced and the doctors informed her that it was incurable.

At that time, Natalia was prescribed chemotherapy and monoclonal antibodies every 21 days, but these did not have the desired effect on her disease.

Natalia had multiple lesions in her liver, had difficulty sleeping, was in constant pain and became depressed.

For her giving up was not an option, she also had the support of her family, especially her sister Melina who, looking for an alternative treatment, found LifEscozul Group in February 2018 and contacted us.

After receiving all her medical documentation Natalia was admitted to our Protocol and in April 2018 she started treatment with LifEscozul (the most effective formulation made with blue scorpion venom), let's see her case below.

  • Clinical Data

    Natalia Ferreyra, 41 years old at the beginning of treatment with LifEscozul.

  • Symptomatology

    Abdominal pain, tiredness, depression.

  • Protocol Start

    April 2018.

  • Specialist assigned to Grupo LifEscozul

    Dr. Aaron Sarmiento

  • Diagnostics

    Breast cancer (intermediate grade invasive carcinoma) with metastasis to the liver.

Background

In August 2017, at 38 years of age, Natalia was diagnosed with cancer in her left breast with metastasis to the liver, and according to the comments of doctors in her country it was an incurable cancer.

In February 2018 she had multiple lesions in both hepatic lobes, the largest of 32 millimeters and lesions of 15 millimeters in D11 and D6.

She was receiving chemotherapy and monoclonal antibodies every 21 days, which she switched to hormonal treatment in March 2018 although she continued to receive the monoclonal antibodies, but her disease and health status remained the same.

In addition Natalia presented with abdominal pain, constant tiredness and depression.

Seeing this picture her sister Melina started looking for other treatment options that would help Natalia to get better, and in February 2018 she found LifEscozul Group.

Melina contacted our Medical Team, we immediately requested all the medical documentation and by April 2018 Natalia started treatment with LifEscozul (escozul, blue scorpion venom, escoazul) under controlled doses by Doctor Aaron Sarmiento.

Evolution with LifEscozul and actual results

APRIL TO JUNE 2018

Natalia and her sister have always maintained frequent communication with us throughout every part of the process, which has allowed us to evaluate her improvement and adjust the doses of LifEscozul (the most effective formulation made with blue scorpion venom) where necessary.

At the end of the first 3 months of treatment with LifEscozul (escozul, blue scorpion venom, escoazul), Natalia reported to us that the pain she was feeling before was diminishing, to the point that she could now perform her daily activities such as riding her bicycle all day and sleeping normally.

Undoubtedly this news had an impact on Natalia and us, our treatment was working much better than we initially anticipated.

However, we decided to increase the dosage looking to maximize these results.

AUGUST TO DECEMBER 2018

By August 2018 new studies were performed on Natalia, in which the presence of the tumor was no longer observed in the left breast or in D6, although the lesion persists in D11. The lesion in the liver remained more or less the same with a maximum diameter of 31 millimeters.

This was a very important result, because it meant a breakthrough in the treatment with LifEscozul (the most effective formulation made with blue scorpion venom).

Two months later, in October 2018 Natalia's tests indicated to us that the lesions in the liver did not show metabolic alteration, that is to say that they were not considered malignant.

This result in conjunction with the disappearance of the tumor in the left breast, indicated that the treatment with LifEscozul (escozul, blue scorpion venom, escoazul) prevented Natalia's cancer from progressing.

Subsequently, all studies performed in December 2018 were negative.

MARCH 2019.

In the month of March 2019 Natalia underwent surgery on her left breast. The results indicated that at the cellular level there were only 10% residual invasive carcinoma cells.

This means that the cancer Natalia suffered from is no longer considered dangerous, overcoming the initial prognosis that indicated that her cancer was incurable.

SEPTEMBER 2019

Natalia's September 2019 tests indicated that her organs were healthy, functioning normally and showed no alterations of any kind.

As of this time Natalia is only under medical follow-up.

2020

Natalia has shown a very remarkable recovery during these two years of treatment with LifEscozul (the most effective formulation made with blue scorpion venom).

All this year she has been kept under control by our Medical Team and continues with the LifEscozul (escozul, blue scorpion venom, escoazul) treatment, which she receives free of charge.

He has not reported a recurrence of the disease and continues to maintain a healthy and active life.

Resumen

In August 2017 Natalia was diagnosed with cancer in her left breast with metastasis to the liver, and according to her doctors' opinion her cancer was incurable.

In February 2018 she had multiple lesions in both hepatic lobes, the largest being 32 millimeters and 15 millimeter lesions in D11 and D6.

She received chemotherapy and monoclonal antibodies, but her disease and health status remained the same. Natalia presented abdominal pain, tiredness and depression.

Her sister Melina found LifEscozul Group and in April 2018 Natalia started with LifEscozul treatment (the most effective formulation made with blue scorpion venom).

Within 3 months of treatment Natalia's pains were decreasing and by August 2018 her studies indicated that the presence of the tumor was no longer observed in the left breast nor in D6.

In October 2018 the lesions in the liver were no longer considered malignant, and from then on all her tests were negative.

In March 2019 Natalia had surgery on her left breast and her post-surgical results indicated that the cancer she suffered from was no longer considered dangerous.

By 2020 Natalia's scans have reported no presence of the disease and her quality of life improved markedly, to the point where she no longer appears to be an oncology patient.

Her case will continue to be monitored by our Medical Team and Natalia will continue with LifEscozul (escozul, blue scorpion venom, escoazul) treatment for at least 3 more years.

We are the LifEscozul Group and Results Define Us.

Next case

Juliana Baquero - Colon Cancer- Resultados con LifEscozul™

Juliana Baquero

In June 2017 Juliana was diagnosed through colonoscopy with colon cancer. She received chemotherapies and radiotherapies, and in December 2017 they removed the tumor which spanned approximately 10cm. Subsequent to the operation she received 8 more chemotherapies with the intention of eliminating any malignant cells or focus that had survived the operation. View more